Skip to main content

and
  1. Article

    Open Access

    Immunogenicity of subcutaneous TNF inhibitors and its clinical significance in real-life setting in patients with spondyloarthritis

    Considerable proportion of patients with SpA have been immunized to the subcutaneous anti-TNF drug they are using. Concomitant use of MTX protects from immunization, whereas SASP does not. Patients with SpA us...

    J. Hiltunen, P. Parmanne, T. Sokka, T. Lamberg, P. Isomäki in Rheumatology International (2022)